Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
CADTH
Record ID 32012000676
English
Authors' recommendations:
Eight cystic fibrosis newborn screening protocols were identified in the reviewed literature. There was strong evidence of high sensitivity of the evaluated screening protocols and suggestive evidence of low positive predictive value (high false screen-positive). The cost of cystic fibrosis newborn screening was estimated for two protocols; the screening cost per newborn ranged from $US 4.48 to $US 6.78.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.cadth.ca/media/pdf//htis/april-2012/RC0346-%20Newborn%20Screening.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Infant, Newborn
- Neonatal Screening
- Cost-Benefit Analysis
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.